{"id":"S2009005023","label":"Palivizumab","description":"","source_url":"https://id.loc.gov/authorities/subjects/sh2009005023","normalized_label":"palivizumab","broader":["http://id.loc.gov/authorities/subjects/sh85005650","http://id.loc.gov/authorities/subjects/sh85005787"],"aliases":["Synagis (Trademark)"],"source_identifier":"http://id.loc.gov/authorities/subjects/sh2009005023","provider":"lcsh","revision":"4f2482947fb5b78e","taxonomy_revision":"f050b5d4780b1289","title":"Palivizumab","url":"/topics/S2009005023","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"5534018246820390500","address_version":"morton4x16-v1","coordinates":[0,478,64495,31744],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}